tiprankstipranks
Trending News
More News >
Resmed (RMD)
NYSE:RMD
US Market
Advertisement

Resmed (RMD) Ratios

Compare
1,101 Followers

Resmed Ratios

RMD's free cash flow for Q3 2025 was $0.59. For the 2025 fiscal year, RMD's free cash flow was decreased by $ and operating cash flow was $0.33. See a summary of the company’s cash flow.
Ratios
TTM
Jun 24Jun 23Jun 22Jun 21
Liquidity Ratios
Current Ratio
3.41 3.12 2.80 1.73 2.53
Quick Ratio
2.49 1.81 1.72 1.23 1.84
Cash Ratio
0.99 0.30 0.40 0.32 0.77
Solvency Ratio
0.70 0.42 0.56 0.36 0.38
Operating Cash Flow Ratio
1.76 0.91 0.51 0.81 1.33
Short-Term Operating Cash Flow Coverage
42.76 21.79 11.05 61.39 66.93
Net Current Asset Value
$ 1.19B$ -253.97M$ 196.38M$ -267.69M$ -566.89M
Leverage Ratios
Debt-to-Assets Ratio
0.11 0.23 0.18 0.17 0.28
Debt-to-Equity Ratio
0.15 0.38 0.27 0.28 0.52
Debt-to-Capital Ratio
0.13 0.28 0.21 0.22 0.34
Long-Term Debt-to-Capital Ratio
0.11 0.26 0.19 0.18 0.32
Financial Leverage Ratio
1.36 1.63 1.52 1.64 1.84
Debt Service Coverage Ratio
31.49 14.58 18.41 19.17 16.79
Interest Coverage Ratio
226.60 23.89 44.83 37.67 20.05
Debt to Market Cap
0.02 0.05 0.03 0.02 0.04
Interest Debt Per Share
5.77 11.09 6.43 5.63 9.28
Net Debt to EBITDA
-0.05 1.00 0.55 0.45 0.84
Profitability Margins
Gross Profit Margin
58.53%55.78%56.57%57.53%58.09%
EBIT Margin
31.83%27.52%27.47%28.54%27.36%
EBITDA Margin
33.96%32.18%32.88%34.38%33.49%
Operating Profit Margin
32.10%26.80%27.96%28.27%27.38%
Pretax Profit Margin
31.41%26.09%26.84%27.64%24.79%
Net Profit Margin
26.15%21.25%21.78%14.84%21.02%
Continuous Operations Profit Margin
13.09%21.25%21.78%14.84%21.02%
Net Income Per EBT
83.26%81.47%81.15%53.70%84.80%
EBT Per EBIT
97.84%97.33%96.02%97.79%90.54%
Return on Assets (ROA)
17.36%13.29%15.30%10.04%13.55%
Return on Equity (ROE)
25.18%21.73%23.19%16.44%24.90%
Return on Capital Employed (ROCE)
24.33%18.89%22.70%23.68%20.32%
Return on Invested Capital (ROIC)
20.14%15.25%18.20%12.60%17.09%
Return on Tangible Assets
30.63%26.17%27.70%19.71%27.64%
Earnings Yield
3.27%2.80%2.55%1.32%2.24%
Efficiency Ratios
Receivables Turnover
5.53 5.99 6.21 5.20 6.11
Payables Turnover
9.36 12.39 9.76 9.84 9.13
Inventory Turnover
2.41 1.87 2.09 2.97 2.97
Fixed Asset Turnover
7.30 6.34 5.68 5.40 5.52
Asset Turnover
0.66 0.63 0.70 0.68 0.64
Working Capital Turnover Ratio
2.36 2.96 3.76 4.04 3.92
Cash Conversion Cycle
178.18 226.54 196.09 155.90 142.56
Days of Sales Outstanding
65.99 60.93 58.75 70.14 59.75
Days of Inventory Outstanding
151.21 195.08 174.75 122.87 122.80
Days of Payables Outstanding
39.01 29.47 37.41 37.10 39.99
Operating Cycle
217.19 256.00 233.50 193.00 182.55
Cash Flow Ratios
Operating Cash Flow Per Share
11.27 4.72 2.40 5.07 5.56
Free Cash Flow Per Share
10.66 3.81 1.34 4.27 4.82
CapEx Per Share
0.60 0.91 1.07 0.80 0.73
Free Cash Flow to Operating Cash Flow
0.95 0.81 0.56 0.84 0.87
Dividend Paid and CapEx Coverage Ratio
4.21 1.77 0.87 2.14 2.42
Capital Expenditure Coverage Ratio
18.66 5.17 2.25 6.31 7.57
Operating Cash Flow Coverage Ratio
1.97 0.44 0.38 0.93 0.62
Operating Cash Flow to Sales Ratio
0.33 0.16 0.10 0.23 0.27
Free Cash Flow Yield
3.90%1.74%0.64%1.73%2.51%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
30.54 35.73 39.28 75.49 44.58
Price-to-Sales (P/S) Ratio
7.98 7.59 8.56 11.21 9.37
Price-to-Book (P/B) Ratio
7.23 7.76 9.11 12.41 11.10
Price-to-Free Cash Flow (P/FCF) Ratio
25.62 57.34 156.94 57.79 39.80
Price-to-Operating Cash Flow Ratio
24.27 46.25 87.20 48.62 34.54
Price-to-Earnings Growth (PEG) Ratio
5.82 2.45 0.62 -3.13 0.85
Price-to-Fair Value
7.23 7.76 9.11 12.41 11.10
Enterprise Value Multiple
23.45 24.60 26.57 33.04 28.82
Enterprise Value
39.99B 33.42B 31.26B 36.32B 28.55B
EV to EBITDA
23.45 24.60 26.57 33.04 28.82
EV to Sales
7.96 7.91 8.74 11.36 9.65
EV to Free Cash Flow
25.56 59.75 160.24 58.59 41.00
EV to Operating Cash Flow
24.19 48.20 89.03 49.30 35.59
Tangible Book Value Per Share
15.45 5.50 7.38 3.89 1.10
Shareholders’ Equity Per Share
37.80 28.14 23.01 19.86 17.30
Tax and Other Ratios
Effective Tax Rate
0.17 0.19 0.19 0.46 0.15
Revenue Per Share
34.23 28.77 24.50 22.00 20.49
Net Income Per Share
8.95 6.12 5.34 3.27 4.31
Tax Burden
0.83 0.81 0.81 0.54 0.85
Interest Burden
0.99 0.95 0.98 0.97 0.91
Research & Development to Revenue
0.06 0.07 0.07 0.07 0.07
SG&A to Revenue
0.00 0.00 0.00 0.00 0.00
Stock-Based Compensation to Revenue
0.02 0.02 0.02 0.02 0.02
Income Quality
1.26 0.77 0.45 1.55 1.29
Currency in USD
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis